Use of prostaglandins in minor cephalopelvic disproportion and abnormal uterine action.
D002508:Cephalometry; D002584:Cervix Uteri / Q000503:physiopathology; D004106:Dilatation; D005260:Female; D006801:Humans; D007263:Infusions, Parenteral; D007744:Obstetric Labor Complications / Q000188:drug therapy* / Q000503:physiopathology; D010121:Oxytocin / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D010387:Pelvimetry; D011247:Pregnancy; D011453:Prostaglandins / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D014591:Uterine Diseases / Q000188:drug therapy* / Q000503:physiopathology; D014593:Uterine Inertia / Q000188:drug therapy
D011453:Prostaglandins; D010121:Oxytocin